Reporting Manager
Bain Capital Life Sciences Fund II, L.P.
Symbol
SVRA
Shares outstanding
176,182,392 shares
Disclosed Ownership
17,600,621 shares
Ownership
10%
Form type
SCHEDULE 13D/A
Filing time
27 Mar 2025, 17:40:52 UTC
Date of event
25 Mar 2025

Quoteable Key Fact

"Bain Capital Life Sciences Fund II, L.P. disclosed 10% ownership in Savara Inc. Common Stock, par value $0.001 per share (SVRA) on 25 Mar 2025."

Quick Takeaways

  • Bain Capital Life Sciences Fund II, L.P. filed SCHEDULE 13D/A for Savara Inc. Common Stock, par value $0.001 per share (SVRA).
  • Disclosed ownership: 10%.
  • Date of event: 25 Mar 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 27 Mar 2025, 17:40.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Bain Capital Life Sciences Fund II, L.P. 10% 17,600,621 0 17,600,621 /s/ Ricky Sun Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC 0001773187
BCIP Life Sciences Associates, LP 10% 17,600,621 0 17,600,621 /s/ Ricky Sun Ricky Sun, Authorized Signatory of Boylston Coinvestors, LLC 0001702921
BCLS II Investco, LP 10% 17,600,621 0 17,600,621 /s/ Ricky Sun Ricky Sun, Partner of Bain Capital Life Sciences Investors, LLC 0001818893